Cytokinetics, Incorporated: BofA Global Research cuts price objective to $81 from $85
CYTK•BofA Global Research cut its price objective for Cytokinetics to $81 from $85.
Related News
KKR charged with misleading EU regulators over Telecom Italia network deal
KKR•
Nasdaq halts trading in Silence Therapeutics pending news at 7:55 a.m.
SLN•
EyePoint plummets after second failure for eye disease drug
EYPT•
FormFactor Inc. target price cut to $150 from $165
FORM•
S&P 500 and Nasdaq futures rise as AI stocks rebound ahead of key earnings
SPY•